# Pharmacia Deutschland GmbH

- Location (FDA's records): Freiburg, DE
- FDA decisions: 10 (2002–2004): 10 510(k) clearances
- Product codes: MSV (4), MID (3), LRM (1), LJM (1), MOB (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 6 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Phadia US, Inc.: 5 (https://510kreport.com/company/phadia-us)
- Bio-Rad Laboratories, Inc.: 1 (https://510kreport.com/company/bio-rad-laboratories)

## Its most-cited devices
- K040451: Varelisa B2 Glycoprotein I Igm Antibodies, Models 18848 and 18896 (2004), cited by 1
- K040450: Varelisa B2 Glycoprotein I Iga Antibodies, Models 18948 and 18996 (2004), cited by 1
- K020752: Varelisa Cardiolipin Igg Antibodies, Models 15548 & 15596 (2002), cited by 1
- K020758: Varelisa Cardiolipin Igm Antibodies, Models 15648 & 15696 (2002), cited by 1
- K041043: Varelisa PR3 Anca, Model Number 17748/17796 (2004), cited by 1
- K040449: Varelisa B2 Glycoprotein I Igg Antibodies, Models 18748 and 18796 (2004), cited by 1

## Recent decisions
- K041043: Varelisa PR3 Anca, Model Number 17748/17796 (Jul 2, 2004)
- K040810: Varelisa Histone Antibodies, Model 16496 (May 14, 2004)
- K040811: Varelisa Ssdna Antibodies, Model 14896 (May 13, 2004)
- K040451: Varelisa B2 Glycoprotein I Igm Antibodies, Models 18848 and 18896 (May 11, 2004)
- K040450: Varelisa B2 Glycoprotein I Iga Antibodies, Models 18948 and 18996 (May 11, 2004)
- K040452: Varelisa B2 Glycoprotein I Antibodies Screen, Models 19048 and 19096 (May 11, 2004)
- K040449: Varelisa B2 Glycoprotein I Igg Antibodies, Models 18748 and 18796 (May 11, 2004)
- K020757: Varelisa Cardiolipin Iga Antibodies, Models 15748 & 15796 (May 2, 2002)

Source page: https://510kreport.com/company/pharmacia-deutschland